Brian Vastag. Show Affiliations »
Abstract
Entities: Chemical
Mesh： See more » Antibodies, Monoclonal/pharmacologyAntibodies, Monoclonal, HumanizedAntineoplastic Agents/pharmacologyAntineoplastic Agents/therapeutic useBenzamidesCarcinoma, Non-Small-Cell Lung/drug therapyErbB Receptors/drug effectsErbB Receptors/geneticsErlotinib HydrochlorideGefitinibHumansImatinib MesylateLung Neoplasms/drug therapyMutationPiperazines/pharmacologyPyrimidines/pharmacologyQuinazolines/pharmacologyQuinazolines/therapeutic useTrastuzumab
Substances： See more » Antibodies, MonoclonalAntibodies, Monoclonal, HumanizedAntineoplastic AgentsBenzamidesPiperazinesPyrimidinesQuinazolinesImatinib MesylateErlotinib HydrochlorideErbB ReceptorsTrastuzumabGefitinib
Year: 2004 PMID： 15367564 DOI： 10.1093/jnci/96.18.1352
Source DB: PubMed Journal: J Natl Cancer Inst ISSN： 0027-8874 Impact factor: 13.506